All Products
Research$200

Tesofensine (NS2330)

Tesofensine is a synthetic small-molecule triple monoamine reuptake inhibitor that blocks dopamine, norepinephrine, and serotonin transporters (DAT, NET, SERT). Originally developed by NeuroSearch A/S for neurodegenerative-disease research, it was later studied in obesity research after weight changes were observed in earlier trials. Supplied as 500mcg x 30 capsules.

Read Research

Product Specifications

  • Format: 500mcg x 30 capsules
  • Class: Triple monoamine reuptake inhibitor
  • Targets: DAT / NET / SERT
  • Documentation available
4.4 / 5.0 rating

Research use only. Not for human or animal use.

Research Summary

  • Tesofensine inhibits monoamine reuptake at DAT (~65 nM), NET (~3 nM), and SERT (~11 nM) in published research.
  • Phase II obesity trials reported dose-related body-weight reductions in published clinical research.
  • Tesofensine belongs to the phenyltropane chemical family — it is not a peptide.
  • It is not FDA approved for any indication and is supplied as a research compound.

Frequently Asked Questions

Important Disclaimer

This page is for educational and informational purposes only. This product is a research chemical sold for laboratory use only. Not intended for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider. These statements have not been evaluated by the FDA.